Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 4, 2013, Pages 770-776

  Kikuchi, Mariko ^a   Itakura, Atsuo ^a   Miki, Akinori ^a   Nishibayashi, Manabu ^a   Ikebuchi, Kenji ^a   Ishihara, Osamu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Consumptive coagulopathy; Dilutional coagulopathy; Fibrinogen; Fibrinogen concentrate; Obstetric hemorrhage

Indexed keywords

D DIMER; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEMOGLOBIN; THROMBOCYTE CONCENTRATE;

ADULT; ADVERSE OUTCOME; ALLERGIC REACTION; AMNION FLUID EMBOLISM; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTIONAL COAGULOPATHY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE; FEMALE; FIBRINOGEN DEFECT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOFIBRINOGENEMIA; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; OBSTETRIC HEMORRHAGE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PLACENTA ACCRETA; PLASMAPHERESIS; PROTHROMBIN TIME; RENAL REPLACEMENT THERAPY; RETAINED PLACENTA; RETROSPECTIVE STUDY; SOLUTIO PLACENTAE; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; THROMBOEMBOLISM; UTERINE ATONY; UTERUS BLEEDING; UTERUS INVERSION;

ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; FEMALE; FIBRINOGEN; HEMOSTATICS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; UTERINE HEMORRHAGE;

EID: 84880001097     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.02058.x     Document Type: Article

References (20)

1. Ministry of Health, Labour and Welfare. Vital Statistics of Japan: Number of Maternal Deaths and Death Rates by Selected Causes (1980, 1985, 1988-2009).
2. McLintock C, James AH. Obstetric hemorrhage. J Thromb Haemost 2011; 9: 1441-1451.
3. Fuller AJ, Bucklin BA. Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 2010; 53: 196-208.
4. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-365.
5. Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008; 106: 725-731.
6. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive hemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-773.
7. Charbit B, Mandelbrot L, Samain E et al. PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-273.
8. Burtelow M, Riley E, Druzin M et al. How we treat: Management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007; 47: 1564-1572.
9. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153-168.
10. Charles J, Lockwood MD. Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 2006; 49: 836-843.
11. Mercier FJ, Bonnet MP. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol 2010; 23: 310-316.
12. Ahonen J, Stefanovic V, Lassila R. Management of postpartum haemorrhage. Acta Anaesthesiol Scand 2010; 54: 1164-1178.
13. Nakayama M, Okagaki R, Suzuki M, Ishihara O, Kanayama N, Itakura A. A case of anaphylactic type amniotic fluid embolism, which showed negative serum Zn-CP1/STN test and was finally diagnosed by autopsy. Jpn J Obstet Gynecol Neonatal Hematol 2012; 21: 23-28.
14. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008; 18: 151-157.
15. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric hemorrhage. Int J Obstet Anesth 2010; 19: 218-223.
16. Morikawa M, Yamada T, Yamada T, Akaishi R, Koyama T, Minakami H. Changes in D-dimer levels after cesarean section in women with singleton and twin pregnancies. Thromb Res 2011; 128: e33-e38.
17. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpartum hemorrhage. Acta Anaesthesiol Scand 2007; 51: 929-936.
18. Oyelese Y, Ananth CV. Postpartum hemorrhage: Epidemiology, risk factors, and causes. Clin Obstet Gynecol 2010; 53: 147-156.
19. Alexander JM, Sarode R, McIntire DD, Burner JD, Leveno KJ. Whole blood in the management of hypovolemia due to obstetric hemorrhage. Obstet Gynecol 2009; 113: 1320-1326.
20. Jan JY, Lin SY, Lin CH, Lee CN, Fan SZ, Han YY. Recombinant activated factor VII as a promising adjuvant therapy for postpartum hemorrhage in the practice of obstetric anesthesia: Experience from a university hospital in Taiwan. J Obstet Gynaecol Res 2011; 37: 901-907. Technology